We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Evgen Pharma Plc | LSE:EVG | London | Ordinary Share | GB00BSVYN304 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 422k | -4.04M | -0.0147 | -0.54 | 2.2M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/3/2021 16:57 | And you are a low life Keep buying mate cos directors refuse to What a fool you are | nico115 | |
10/3/2021 16:57 | Don't be so rude | nico115 | |
10/3/2021 16:23 | "Raise 3 x original intended size" Where are you getting this from nico? Looks to me like they intended to raise £10m, and raised £10m (plus the £1m from the open offer). | on target | |
10/3/2021 16:22 | 3 red flags Griffiths selling No director buying at near to all time lows Raise 3 x original intended size Buy sell or hold ?I'm a holder | nico115 | |
10/3/2021 16:18 | 2 x 5M now. Some kind of transfer presumably? | on target | |
10/3/2021 12:39 | Seems to me that the share price has already formed a solid base and the only likely way forward is a recovery towards 10p DYOR | clocktower | |
10/3/2021 11:44 | Prof Chalmers, Lead investigator for SFX-01 Covid/ARDS patient trials, is on the organisation committee for the following event, and so fingers crossed he will have some good news to report on SFX 01's prospects for Covid/ARDS...Gla ;-) A full-day virtual event dedicated to COVID-19, where top level faculty will share the latest advances, data and best practices relating to SARS-CoV-2 and COVID-19. “This event brings together world-leaders tackling COVD-19 and how different digital approaches to big data will help us to defeat the pandemic”  Target audience: ODRAGON consortium members JClinicians, researchers, nurses, physiotherapists, and other healthcare workersEpidemiologis Background The DRAGON project is coordinated by the University of Maastricht with Radiomics as the Project Lead, and partners comprised of high-tech small and medium-sized enterprises (SMEs), academic research institutes, biotechnology and pharmacological partners, and ELF and ERS. Funded by the Innovative Medicines Initiative (IMI), it will use AI and machine learning to deliver a patient-centred decision support system that will enable stakeholders to participate in the development of rapid precise diagnosis and prognosis. “The application of digital imaging together with clinical data to inform clinical decisions through artificial intelligence is very exciting. The DRAGON project offers to do this as part of our response to the pandemic.”&nbs | moneymunch | |
10/3/2021 08:54 | Yep, certainly orderly to avoid any influence on share price either way....and it also appears that we have an orderly disclosure of shareholdings, which is a good thing imho as the placing dust settles, and look forward to finding out which other high quality investors have joined the party. Gla :-) | moneymunch | |
10/3/2021 08:37 | No mm owning up to the business, so insti to insti i guess. | bumpa33 | |
10/3/2021 07:53 | Be good if he has gone, he’s a bit too much of a ‘trader’ for a major shareholder imv. | bumpa33 | |
09/3/2021 17:22 | If Griffiths has caused a short term overhang then this really is a gift for everyone around 8p. | brasso3 | |
09/3/2021 17:18 | Hopefully so, and certainly an orderly worked trade by the looks of it. Gl :-) | moneymunch | |
09/3/2021 17:03 | Could be, that's around 2.5% / 5% pre-placing. If it is I wonder if another large holder picked it up, as there doesn't seem to have been enough buys in the market to fill it? | on target | |
09/3/2021 16:44 | A 7m trade....was that the last of Griffiths??? | moneymunch | |
09/3/2021 14:40 | Nice one, On Target, that's an excellent review by Procative Investors. Gl :-) So good and so compelling, it's now in the header. Gla :-) | moneymunch | |
09/3/2021 14:19 | Another top up for me. I am starting to get a bit heavy on EVG! | brasso3 | |
09/3/2021 13:23 | Guess we'll never know now he's under 3%, although he did have 12.25m shares which represented 8.9% which would now equate to c4.5% of the new enlarged capital, and so he still could be holding plenty despite selling a few??? Gl ;-) | moneymunch | |
09/3/2021 12:32 | Agree wih your sentiments, On Taget, but problem is that we do not know if Griffiths is completely out or not. Theoretically he could still have as many as 8 million left, but by the same token it is possible that he has none left. | mesquida | |
09/3/2021 11:48 | Yep looks like he didn't take part in the placing and has reduced as well so now below 3%. Out with the old, in with the new. Hopefully we'll get a similar RNS from Intertrader who I believe were at about 4% pre-placing. Will be great to see the back of the sellers who've been dragging this down. | on target | |
09/3/2021 11:40 | Richard Griffiths TR1 - happier to see him off/gone - assuming I’ve got it right this time...! | bumpa33 | |
09/3/2021 09:40 | Joined the party here, been hovering for a while but your chart convinced me Wan. | lottsgold | |
09/3/2021 08:37 | hopefully it'll start to move up again now :-) Cheers Wan :-) free stock charts from uk.advfn.com | wanobi |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions